Literature DB >> 7886323

Effect of critical illness on microbial translocation and gastrointestinal mucosa permeability.

M P Fink1.   

Abstract

It has been hypothesized that the barrier function of the gastrointestinal tract is deranged in patients with trauma, sepsis, or other critical illnesses. Derangements in intestinal barrier function might lead to bloodstream invasion by gut-derived microbes and/or activation of inflammatory cells in the submucosa of the intestine or within the liver. Activated immune cells are capable of releasing a number of inflammatory mediators, including eicosanoids and cytokines, which have been implicated in the pathogenesis of the multiple organ dysfunction syndrome (MODS). Thus, gut-barrier dysfunction might be primary factor leading to MODS in patients with critical illness. Two distinct forms of gut-barrier dysfunction have been described. The first, called translocation, appears to a transcellular process, whereby particulate antigens, including viable microbes, are transported across enterocytes into the submucosal compartment. The second is an increase in the paracellular permeability of the intestinal epithelium, which permits increased transmucosal absorption of water-soluble macromolecules. Pathological increases in both translocation and permeability occur in a number of animal models of critical illness. Moreover, a number of studies have documented that intestinal permeability is increased in humans with trauma, sepsis, burns, or other serious, acute medical problems. Nevertheless, convincing data to establish a causal link between gut-barrier dysfunction and organ failure in humans are lacking, and the importance of translocation and/or mucosal hyperpermeability on the development of MODS in patients remains to be elucidated.

Entities:  

Mesh:

Year:  1994        PMID: 7886323

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  11 in total

Review 1.  Cytokine regulation of epithelial permeability and ion transport.

Authors:  D M McKay; A W Baird
Journal:  Gut       Date:  1999-02       Impact factor: 23.059

2.  Clostridium difficile infection as a cause of severe sepsis.

Authors:  S E Lowenkron; J Waxner; P Khullar; J S Ilowite; M S Niederman; A M Fein
Journal:  Intensive Care Med       Date:  1996-09       Impact factor: 17.440

Review 3.  Bacterial translocation in surgical patients.

Authors:  J MacFie
Journal:  Ann R Coll Surg Engl       Date:  1997-05       Impact factor: 1.891

4.  Basolateral potassium (IKCa) channel inhibition prevents increased colonic permeability induced by chemical hypoxia.

Authors:  A Loganathan; J E Linley; I Rajput; M Hunter; J P A Lodge; G I Sandle
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-10-21       Impact factor: 4.052

5.  Orexigenic hormone ghrelin ameliorates gut barrier dysfunction in sepsis in rats.

Authors:  Rongqian Wu; Weifeng Dong; Xiaoling Qiang; Haichao Wang; Steven A Blau; Thanjavur S Ravikumar; Ping Wang
Journal:  Crit Care Med       Date:  2009-08       Impact factor: 7.598

6.  Reversing established sepsis in rats with human vasoactive hormone adrenomedullin and its binding protein.

Authors:  Rongqian Wu; Shinya Higuchi; Weifeng Dong; Youxin Ji; Mian Zhou; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  Mol Med       Date:  2008-10-10       Impact factor: 6.354

7.  Enhancing apoptotic cell clearance mitigates bacterial translocation and promotes tissue repair after gut ischemia-reperfusion injury.

Authors:  Rongqian Wu; Weifeng Dong; Zhimin Wang; Asha Jacob; Tianpen Cui; Ping Wang
Journal:  Int J Mol Med       Date:  2012-06-26       Impact factor: 4.101

8.  Natural selection for imprecise vertical transmission in host-microbiota systems.

Authors:  Marjolein Bruijning; Lucas P Henry; Simon K G Forsberg; C Jessica E Metcalf; Julien F Ayroles
Journal:  Nat Ecol Evol       Date:  2021-12-23       Impact factor: 19.100

9.  Orexigenic hormone ghrelin attenuates local and remote organ injury after intestinal ischemia-reperfusion.

Authors:  Rongqian Wu; Weifeng Dong; Youxin Ji; Mian Zhou; Corrado P Marini; Thanjavur S Ravikumar; Ping Wang
Journal:  PLoS One       Date:  2008-04-23       Impact factor: 3.240

10.  The adenosine deaminase inhibitor erythro-9-[2-hydroxyl-3-nonyl]-adenine decreases intestinal permeability and protects against experimental sepsis: a prospective, randomised laboratory investigation.

Authors:  Nalan Kayhan; Benjamin Funke; Lars Oliver Conzelmann; Harald Winkler; Stefan Hofer; Jochen Steppan; Heinfried Schmidt; Hubert Bardenheuer; Christian-Friedrich Vahl; Markus A Weigand
Journal:  Crit Care       Date:  2008-10-13       Impact factor: 9.097

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.